Trial Profile
Impact of natalizumab treatment on cerebrospinal fluid and serum concentrations of oxysterols
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 25 Oct 2016 New trial record